Fields of interest and research include pathological and molecular aspects of liver tumorigenesis with a specific interest of hepatocellular carcinomas developed in patients with metabolic syndrome. Her team has developed original in situ proteomic approach (MALDI imaging) for identification of tissue biomarkers, and ex vivo culture model of human tumor slices for evaluation of therapeutic molecules.